IPSC
IPSC
NASDAQ · Biotechnology

Century Therapeutics Inc

$1.70
+0.03 (+1.80%)
As of Feb 8, 2:08 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 24.41M 24.82M 19.44M
Net Income -1,389,193 -1,166,783 -1,174,826
EPS
Profit Margin -5.7% -4.7% -6.0%
Rev Growth +22.2% +16.0% +16.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 27.74M 29.45M 33.99M
Total Equity 103.32M 95.78M 103.82M
D/E Ratio 0.27 0.31 0.33
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,777,503 -1,974,923 -1,572,213
Free Cash Flow -1,484,406 -1,631,995 -1,127,049